Hugo is about to joust da Vinci. It’s not a battle between Renaissance geniuses. Instead, a commercial fight is brewing ...

With the U.S. authorization for urologic procedures, “there is now choice” for hospitals that want to expand their robotic ...

Medtronic (NYSE: MDT) announced today that the FDA cleared its Hugo robotic-assisted surgery system for use in urologic surgical procedures.

The long-awaited FDA clearance sets up a showdown in the surgical robotics market between Medtronic and Intuitive Surgical.

Hugo is heading to the U.S., with Medtronic finally securing a stateside clearance for its robotic surgery platform. | The ...

FDA clears the Medtronic Hugo™ robotic-assisted surgery system for urologic procedures. NORTHAMPTON, MA / ACCESS Newswire / ...

FDA clears the Medtronic Hugo robotic-assisted surgery system for urologic procedures. NORTHAMPTON, MA / ACCESS Newswire / December 15, 2025 / James Choate-Deeds and his wife Caryn held hands and brac ...

Medtronic’s Hugo robotic surgery system earns FDA clearance, ending Intuitive’s long-held dominance and reshaping the future of soft-tissue robotics.

Medtronic's Hugo surgical robot gained FDA clearance for urologic procedures, opening U.S. market entry and setting the stage ...

In early December 2025, Medtronic’s board approved a US$0.71 per-share cash dividend for the third quarter of fiscal 2026, payable on January 16, 2026, and the company secured FDA clearance for its ...

Minneapolis-based Medtronic, the world’s largest standalone medical device manufacturer, is developing a new robotic surgical system expected to be released by 2019. Robotically assisted surgery ...